Incyte Corporation
INCY
$98.07
-$1.97-1.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.22% | 18.09% | 18.87% | 17.13% | 14.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.22% | 18.09% | 18.87% | 17.13% | 14.76% |
| Cost of Revenue | -17.20% | -21.66% | -12.94% | 54.80% | 52.87% |
| Gross Profit | 102.60% | 108.63% | 85.46% | -20.19% | -24.90% |
| SG&A Expenses | 10.78% | 12.03% | 14.35% | 10.59% | 6.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.71% | -11.61% | -4.57% | 37.59% | 36.59% |
| Operating Income | 1,494.43% | 5,976.69% | 1,385.89% | -70.58% | -87.05% |
| Income Before Tax | 425.68% | 479.94% | 259.53% | -69.11% | -62.04% |
| Income Tax Expenses | 33.02% | 65.57% | 54.26% | 7.44% | 20.03% |
| Earnings from Continuing Operations | 3,844.96% | 3,559.21% | 795.08% | -97.15% | -94.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3,844.96% | 3,559.21% | 795.08% | -97.15% | -94.54% |
| EBIT | 1,494.43% | 5,976.69% | 1,385.89% | -70.58% | -87.05% |
| EBITDA | 728.90% | 1,079.01% | 578.91% | -62.66% | -76.48% |
| EPS Basic | 2,012.89% | 3,563.21% | 1,088.25% | -88.79% | -88.32% |
| Normalized Basic EPS | 487.43% | 655.89% | 416.93% | -50.98% | -65.01% |
| EPS Diluted | 2,291.76% | 4,144.74% | 1,119.66% | -90.36% | -89.87% |
| Normalized Diluted EPS | 496.76% | 664.94% | 419.07% | -52.46% | -66.22% |
| Average Basic Shares Outstanding | -5.75% | -9.65% | -13.19% | -10.98% | -7.39% |
| Average Diluted Shares Outstanding | -4.24% | -8.25% | -11.97% | -10.55% | -7.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |